Related Experiment Videos
Protecting the vasculature: an eye toward the future
1Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.
The American Journal of Cardiology
|November 20, 1990
Summary
Amlodipine, a novel calcium antagonist, shows promise in preventing atherosclerosis and improving survival in hypertensive rats. Its unique properties offer potential therapeutic benefits for cardiovascular diseases.
Area of Science:
- Cardiovascular Pharmacology
- Atherosclerosis Research
- Drug Development
Background:
- Calcium antagonists, initially for angina, are now used for hypertension and investigated for atherosclerosis.
- Newer, long-acting, tissue-specific calcium antagonists are emerging.
- Amlodipine, a dihydropyridine calcium antagonist, exhibits distinct pharmacological properties.
Purpose of the Study:
- To investigate the potential protective role of amlodipine in atherosclerosis.
- To evaluate amlodipine's effects on vascular health in preclinical models.
Main Methods:
- Oral administration of amlodipine to rabbits on a high-cholesterol diet.
- Assessment of atheroma formation in rabbits.
- Evaluation of survival rates in stroke-prone hypertensive rats treated with amlodipine.
Main Results:
- Amlodipine reduced atheroma formation in hypercholesterolemic rabbits.
- Amlodipine significantly increased survival rates (p < 0.001) in stroke-prone hypertensive rats.
- Pharmacological differences noted in pH optimum, binding kinetics, and allosteric interactions compared to other dihydropyridines.
Conclusions:
- Amlodipine demonstrates potential atheroprotective and vasculoprotective effects.
- Its unique pharmacological profile may offer advantages in managing cardiovascular disorders.
- Further research into amlodipine's role in atherosclerosis and hypertension is warranted.